Found: 65
Select item for more details and to access through your institution.
Thrombopoietin receptor agonist for treatment of immune thrombocytopenia in pregnancy: a narrative review.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211001139
- By:
- Publication type:
- Article
Mitapivat, a novel pyruvate kinase activator, for the treatment of hereditary hemolytic anemias.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211066070
- By:
- Publication type:
- Article
Venetoclax-containing regimens in acute myeloid leukemia.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620720986646
- By:
- Publication type:
- Article
Venetoclax combination therapy with hypomethylating agents in young adults with relapsed/refractory acute myeloid leukaemia.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211040335
- By:
- Publication type:
- Article
Should patients receive consolidation chemotherapy before reduced intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission?
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211001135
- By:
- Publication type:
- Article
Rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in diffuse large B-cell lymphoma.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721989579
- By:
- Publication type:
- Article
Second-line administration of thrombopoietin receptor agonists in immune thrombocytopenia: Italian Delphi-based consensus recommendations.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211048361
- By:
- Publication type:
- Article
Clinicopathological characteristics and long-term prognosis of monoclonal immunoglobulin light chain associated Fanconi syndrome.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620720983127
- By:
- Publication type:
- Article
Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinib.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211010875
- By:
- Publication type:
- Article
Advances in therapeutic options for newly diagnosed, high-risk AML patients.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211001138
- By:
- Publication type:
- Article
Current evidence and the emerging role of eltrombopag in severe aplastic anemia.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721998126
- By:
- Publication type:
- Article
The use of tafasitamab in diffuse large B-cell lymphoma.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211027458
- By:
- Publication type:
- Article
Design of an international investigator-initiated study on MOdern Treatment of Inhibitor-positiVe pATiEnts with haemophilia A (MOTIVATE).
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211032452
- By:
- Publication type:
- Article
Current and emerging treatment options in primary mediastinal B-cell lymphoma.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211048959
- By:
- Publication type:
- Article
The role of acalabrutinib in adults with chronic lymphocytic leukemia.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721990553
- By:
- Publication type:
- Article
Bortezomib-based therapy in non-transplant multiple myeloma patients: a retrospective cohort study from the FABIO project.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721996488
- By:
- Publication type:
- Article
Prophylactic management of patients with von Willebrand disease.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211064064
- By:
- Publication type:
- Article
Ferumoxytol for the treatment of iron deficiency and iron-deficiency anemia of pregnancy.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211018042
- By:
- Publication type:
- Article
Voxelotor: alteration of sickle cell disease pathophysiology by a first-in-class polymerization inhibitor.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211001136
- By:
- Publication type:
- Article
The evolving role of Bruton's tyrosine kinase inhibitors in chronic lymphocytic leukemia.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721989588
- By:
- Publication type:
- Article
Treatment with eltrombopag of severe immune thrombocytopenia and hemolytic anemia associated with COVID-19 pneumonia: a case report.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211011353
- By:
- Publication type:
- Article
Challenges of biological monitoring in a hemophilia A patient without inhibitors on emicizumab undergoing major orthopedic surgery: a case report.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211040345
- By:
- Publication type:
- Article
Acute myeloid leukemia with CPSF6–RARG fusion resembling acute promyelocytic leukemia with extramedullary infiltration.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620720976984
- By:
- Publication type:
- Article
Emicizumab in acquired haemophilia A: about two clinical cases and literature review.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211038193
- By:
- Publication type:
- Article
Features of indeterminate results of QuantiFERON-TB Gold In-Tube test in patients with haematological malignancies.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211028437
- By:
- Publication type:
- Article
Interferon-α may help prevent molecular relapse of chronic myeloid leukemia after the discontinuation of tyrosine kinase inhibitors.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620720986643
- By:
- Publication type:
- Article
Expert opinion on the UK standard of care for haemophilia patients with inhibitors: a modified Delphi consensus study.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211007058
- By:
- Publication type:
- Article
Safety and efficacy of a single total dose infusion (1020 mg) of ferumoxytol.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211006022
- By:
- Publication type:
- Article
Case report: successful perioperative management of patients with haemophilia A using an extended half-life factor VIII (Efmoroctocog alfa) during neurosurgical procedures.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721993686
- By:
- Publication type:
- Article
Update on the role of copanlisib in hematologic malignancies.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211006027
- By:
- Publication type:
- Article
Hepatic venoocclusive disease/sinusoidal obstruction syndrome with normal portal vein flow mimicking aggravated chronic hepatic GVHD following inotuzumab ozogamicin salvage therapy: a case report of pathologic-radiologic discrepancy.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211066176
- By:
- Publication type:
- Article
Cytomegalovirus prophylaxis using low-dose valganciclovir in patients with acute leukemia undergoing allogeneic hematopoietic stem-cell transplantation.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721998124
- By:
- Publication type:
- Article
The value of survival gains from therapeutic innovations for US patients with relapsed/refractory multiple myeloma.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211027463
- By:
- Publication type:
- Article
Case series: MRD negativity assessment using 11 C-Acetate PET with 3-weekly daratumumab-based quadruplet induction in newly diagnosed multiple myeloma.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211030369
- By:
- Publication type:
- Article
Current and novel BTK inhibitors in Waldenström's macroglobulinemia.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721989586
- By:
- Publication type:
- Article
Natural-killer cell cytotoxicity as a diagnostic and prognostic marker for adult patients with secondary hemophagocytic lymphohistiocytosis: a prospective phase II observational study.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211020544
- By:
- Publication type:
- Article
The role of idecabtagene vicleucel in patients with heavily pretreated refractory multiple myeloma.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211019622
- By:
- Publication type:
- Article
Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211013987
- By:
- Publication type:
- Article
Differential effects of donor lymphocyte infusion upon treatment response and GVHD according to relapse level and donor sources in patients with myelodysplastic syndrome.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211043748
- By:
- Publication type:
- Article
Busulfan plus melphalan versus melphalan alone conditioning regimen after bortezomib based triplet induction chemotherapy for patients with newly diagnosed multiple myeloma.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211012985
- By:
- Publication type:
- Article
Bortezomib in autoimmune hemolytic anemia and beyond.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211046428
- By:
- Publication type:
- Article
Discontinuation of the renin–angiotensin system inhibitors improves erythropoiesis in patients with lower-risk myelodysplastic syndromes.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620720958299
- By:
- Publication type:
- Article
A 10-fold and greater increase in D-dimer at admission in COVID-19 patients is highly predictive of pulmonary embolism in a retrospective cohort study.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211048364
- By:
- Publication type:
- Article
Ibrutinib effect in acquired von Willebrand syndrome secondary to Waldenström macroglobulinemia.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211039326
- By:
- Publication type:
- Article
Integration of cell therapies and bispecific antibodies into the treatment pathway of relapsed diffuse large B-cell lymphoma.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Addition of chemotherapy to nivolumab after PD-1 inhibitor failure as bridge to allogeneic stem cell transplantation in classical Hodgkin's lymphoma: report on three cases and literature review.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211038181
- By:
- Publication type:
- Article
Subcutaneous daratumumab and hyaluronidase-fihj in newly diagnosed or relapsed/refractory multiple myeloma.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620720987075
- By:
- Publication type:
- Article
B-cell maturation antigen (BCMA) in multiple myeloma: the new frontier of targeted therapies.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721989585
- By:
- Publication type:
- Article
The role of axicabtagene ciloleucel as a treatment option for patients with follicular/marginal zone lymphoma.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211017788
- By:
- Publication type:
- Article
Current treatment options for aggressive non-Hodgkin lymphoma in elderly and frail patients: practical considerations for the hematologist.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721996484
- By:
- Publication type:
- Article